Asthma and COPD affect over 500 million people worldwide. Learn more from Sven Dethlefs, EVP Global Marketing & Portfolio and International Markets, as he discusses how Teva is trying to address respiratory diseases through digital health solutions.
At Teva, we strive to deliver quality medicines to patients around the world with integrity and ethical business practices. What we do is important, but how we do it is just as important. Learn more:
You are about to leave the Teva Pharmaceuticals global website
Teva Pharmaceuticals is not responsible for the accuracy or compliance with laws of information on any third party websites.